| AD | Alzheimer’s disease |
| Aβ | β-amyloid peptide |
| ADP | Adenosine diphosphate |
| AMP | Adenosine monophosphate |
| ALS | Amyotrophic lateral sclerosis |
| ASD | Autism spectrum disorder |
| ATP | Adenosine 5′-triphosphate |
| BBB | Blood brain barrier |
| BMMCs | Bone marrow-derived mast cells |
| CCL | Chemokine (C-C motif) ligand |
| CCR | C-C chemokine receptor type |
| CNS | Central nervous system |
| EAE | Experimental autoimmune encephalomyelitis |
| FcɛRI | High-affinity IgE receptor |
| FcγR | Fc-gamma receptor |
| IL | Interleukin |
| KO | Knockout |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MC | Mast cell |
| MS | Multiple sclerosis |
| PAR2 | Protease activated receptor 2 |
| PD | Parkinson’s disease |
| SSA | Serum amyloid A |
| TG2 | Tissue transglutaminase 2 |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor alpha |